![](/img/cover-not-exists.png)
Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
Mavrou, A, Brakspear, K, Hamdollah-Zadeh, M, Damodaran, G, Babaei-Jadidi, R, Oxley, J, Gillatt, D A, Ladomery, M R, Harper, S J, Bates, D O, Oltean, SLanguage:
english
Journal:
Oncogene
DOI:
10.1038/onc.2014.360
Date:
November, 2014
File:
PDF, 1.82 MB
english, 2014